Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans

BACKGROUND Prucalopride (R093877) is a selective and specific 5HT4 agonist, the first of a new chemical class of benzofurans, with gastrointestinal prokinetic activities in vitro. AIMS To evaluate the effects of prucalopride on gastrointestinal and colonic transit. METHODS A validated scintigraphic technique was used to measure gastrointestinal and colonic transit over 48 hours in 50 healthy volunteers. For seven days, each subject received a daily dose of 0.5, 1, 2, or 4 mg prucalopride, or placebo in a double blind, randomised fashion. The transit test was performed over the last 48 hours. RESULTS There were significant accelerations of overall colonic transit at 4, 8, 24, and 48 hours (p<0.05) and proximal colonic emptying t1/2 (p<0.05). The 0.5, 2, and 4 mg doses of prucalopride were almost equally effective and accelerated colonic transit compared with placebo. Prucalopride did not significantly alter gastric emptying (p>0.5) or small bowel transit (overall p=0.12). The medication appeared to be well tolerated during the seven day treatment of healthy subjects. CONCLUSION Prucalopride accelerates colonic transit, partly by stimulating proximal colonic emptying, but does not alter gastric or small bowel transit in healthy human subjects. Prucalopride deserves further study in patients with constipation.

[1]  M. Kamm,et al.  Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers , 1998, Gut.

[2]  M. Camilleri,et al.  Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  N. Bunnett,et al.  Turning off the signal: mechanisms that attenuate signaling by G protein-coupled receptors. , 1997, The American journal of physiology.

[4]  A. Andriulli,et al.  Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin‐dependent) diabetes mellitus , 1997, Alimentary pharmacology & therapeutics.

[5]  J. Schuurkes,et al.  Characterization of the contraction to 5‐HT in the canine colon longitudinal muscle , 1997, British journal of pharmacology.

[6]  M. Camilleri,et al.  Motility and tone of the left colon in constipation: a role in clinical practice? , 1996, The American journal of gastroenterology.

[7]  M. Kamm,et al.  Gastrointestinal transit in patients with idiopathic megarectum , 1996, Diseases of the colon and rectum.

[8]  C. Heyneman,et al.  Cisapride for The Treatment of Chronic Idiopathic Constipation , 1995, The Annals of pharmacotherapy.

[9]  M. Korsten,et al.  The effect of cisapride on segmental colonic transit time in patients with spinal cord injury. , 1995, The American journal of gastroenterology.

[10]  Muller Sa.  Cisapride in chronic idiopathic constipation: can the colon be re-educated? Bavarian Constipation Study Group. , 1995 .

[11]  M. Camilleri,et al.  Audit of constipation in a tertiary referral gastroenterology practice. , 1995, The American journal of gastroenterology.

[12]  S. Müller-lissner.  Cisapride in chronic idiopathic constipation: can the colon be re-educated? Bavarian Constipation Study Group. , 1995, European journal of gastroenterology & hepatology.

[13]  L. Wiseman,et al.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. , 1994, Drugs.

[14]  L. Melton,et al.  Functional constipation and outlet delay: a population-based study. , 1993, Gastroenterology.

[15]  K E Britton,et al.  Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. , 1993, Gut.

[16]  J. Dent,et al.  Dual effects of cisapride on gastric emptying and antropyloroduodenal motility. , 1993, The American journal of physiology.

[17]  K. Schimrigk,et al.  Cisapride treatment of constipation in parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[18]  P. Zhong,et al.  Molecular biology of serotonin receptors. , 1992, The Journal of clinical psychiatry.

[19]  M. Camilleri,et al.  Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders. , 1992, Gastroenterology.

[20]  D. Ilstrup,et al.  Evaluation and surgical treatment of severe chronic constipation. , 1991, Annals of surgery.

[21]  M. Camilleri,et al.  Scintigraphic measurement of regional gut transit in idiopathic constipation. , 1991, Gastroenterology.

[22]  M. Camilleri,et al.  Transit of solids through the human colon: regional quantification in the unprepared bowel. , 1990, The American journal of physiology.

[23]  I. Mena,et al.  Postprandial colonic transit and motor activity in chronic constipation. , 1990, Gastroenterology.

[24]  H. Kuijpers.  Application of the colorectal laboratory in diagnosis and treatment of functional constipation , 1990, Diseases of the colon and rectum.

[25]  A. Zinsmeister,et al.  A patient questionnaire to identify bowel disease. , 1989, Annals of internal medicine.

[26]  A. Zinsmeister,et al.  Human gastric emptying and colonic filling of solids characterized by a new method. , 1989, The American journal of physiology.

[27]  I. Forgacs.  GASTROENTEROLOGY , 1988, The Lancet.

[28]  B. Krevsky,et al.  The effect of oral cisapride on colonic transit , 1987, Alimentary pharmacology & therapeutics.

[29]  J. Reynolds,et al.  Chronic severe constipation , 1987 .

[30]  N. Read,et al.  Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects. , 1987, Gut.

[31]  J. Reynolds,et al.  Prospective Motility Studies in 25 Consecutive Patients , 1987 .

[32]  S. Cohen,et al.  Chronic severe constipation. Prospective motility studies in 25 consecutive patients. , 1987, Gastroenterology.

[33]  M. Camilleri,et al.  Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. , 1986, Gastroenterology.

[34]  D. Drossman,et al.  Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. , 1982, Gastroenterology.